Skip to Content

Campral Approval History

FDA Approved: Yes (Discontinued) (First approved July 29, 2004)
Brand name: Campral
Generic name: acamprosate calcium
Dosage form: Delayed-Release Tablets
Company: Allergan plc
Treatment for: Alcohol Dependence

Marketing Status: Discontinued

Campral (acamprosate calcium) is a synthetic compound resembling the endogenous amino acid homotaurine indicated for treating alcohol dependence.

Development History and FDA Approval Process for Campral

DateArticle
Jul 29, 2004Approval Campral Forest Laboratories, Inc. and Merck - Treatment for Alcoholism

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide